Biotech

All Articles

Turnstone lays off 60%, shakes up C-suite to stretch out money

.Turnstone Biologics is reducing its headcount by 60% and also shaking up its own C-suite so as to k...

Gilead gives up on $15M MASH wager after mulling preclinical records

.In a year that has observed an authorization as well as a boating of readouts for metabolic dysfunc...

Texas biotech centers cancer deal, pins really hopes on weight problems

.Alaunos Therapies is actually axing an arrangement along with Precigen, surrendering licensing righ...

Capricor allotments a lot more records for DMD treatment after triggering BLA

.Capricor Rehabs is actually taking a success lap for their period 2 Duchenne muscular dystrophy (DM...

FDA locations Kezar lupus trial in grip observing 4 individual deaths

.The FDA has positioned Kezar Lifestyle Sciences' lupus test on hold after the biotech hailed 4 deat...

Phase 3 Scholar Stone test reaches SMA objective, delivering stockpile 200%

.A phase 3 trial of Historian Stone's spinal muscular atrophy (SMA) prospect has attacked its primar...

CAMP 4 is actually most recent to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Therapeutics has marked out plans for a $67 thousand IPO, along with inflammation...

Galecto acquires leukemia medicine, goes down bone cancer cells property in pivot

.A year after the failure of an idiopathic pulmonary fibrosis prospect sent Galecto on a hunt for sa...

Judo tosses down $100M to knock out renal illness

.Taking the floor covering is actually Judo Bio, an up-and-coming biotech equipped along with $100 t...

AstraZeneca spends CSPC $100M for preclinical heart problem medicine

.AstraZeneca has settled CSPC Drug Team $100 thousand for a preclinical heart attack medication. The...